AMPK in health and disease
GR Steinberg, BE Kemp - Physiological reviews, 2009 - journals.physiology.org
The function and survival of all organisms is dependent on the dynamic control of energy
metabolism, when energy demand is matched to energy supply. The AMP-activated protein …
metabolism, when energy demand is matched to energy supply. The AMP-activated protein …
eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues
Nitric oxide production in response to flow-dependent shear forces applied on the surface of
endothelial cells is a fundamental mechanism of regulation of vascular tone, peripheral …
endothelial cells is a fundamental mechanism of regulation of vascular tone, peripheral …
Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure
S Gundewar, JW Calvert, S Jha, I Toedt-Pingel… - Circulation …, 2009 - Am Heart Assoc
Clinical studies have reported that the widely used antihyperglycemic drug metformin
significantly reduces cardiac risk factors and improves clinical outcomes in patients with …
significantly reduces cardiac risk factors and improves clinical outcomes in patients with …
Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase
H Sasaki, H Asanuma, M Fujita, H Takahama… - Circulation, 2009 - Am Heart Assoc
Background—Some studies have shown that metformin activates AMP-activated protein
kinase (AMPK) and has a potent cardioprotective effect against ischemia/reperfusion injury …
kinase (AMPK) and has a potent cardioprotective effect against ischemia/reperfusion injury …
[HTML][HTML] AMPK: Lessons from transgenic and knockout animals
B Viollet, Y Athea, R Mounier, B Guigas… - Frontiers in …, 2009 - ncbi.nlm.nih.gov
AMP-activated protein kinase (AMPK), a phylogenetically conserved serine/threonine
protein kinase, has been proposed to function as a 'fuel gauge'to monitor cellular energy …
protein kinase, has been proposed to function as a 'fuel gauge'to monitor cellular energy …
Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion
D Qi, X Hu, X Wu, M Merk, L Leng… - The Journal of …, 2009 - Am Soc Clin Investig
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that also
modulates physiologic cell signaling pathways. MIF is expressed in cardiomyocytes and …
modulates physiologic cell signaling pathways. MIF is expressed in cardiomyocytes and …
Retracted: Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathy
H Ma, SY Li, P Xu, SA Babcock… - Journal of cellular …, 2009 - Wiley Online Library
Diabetic cardiomyopathy is manifested by compromised systolic and diastolic function. This
study was designed to examine the role of advanced glycation endproduct (AGE) and AGE …
study was designed to examine the role of advanced glycation endproduct (AGE) and AGE …
AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
AMPK (AMP-activated protein kinase) is a heterotrimetric enzyme that is expressed in many
tissues, including the heart and vasculature, and plays a central role in the regulation of …
tissues, including the heart and vasculature, and plays a central role in the regulation of …
Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo
RS Lee-Young, SR Griffee, SE Lynes, DP Bracy… - Journal of Biological …, 2009 - ASBMB
AMP-activated protein kinase (AMPK) has been postulated as a super-metabolic regulator,
thought to exert numerous effects on skeletal muscle function, metabolism, and enzymatic …
thought to exert numerous effects on skeletal muscle function, metabolism, and enzymatic …
AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of …
Background—Diabetes increases the morbidity/mortality of ischemic heart disease, but the
underlying mechanisms are incompletely understood. Deficiency of both AMP-activated …
underlying mechanisms are incompletely understood. Deficiency of both AMP-activated …